WPRIM Management System> DCMS> Journal of Experimental Hematology> 2013> 21> 1

Volume: 21 Issue: 1

1. Research on NPM1 gene mutations in acute myeloid leukemia. Page:258—262
2. Molecular mechanism of thrombopoietin signal pathways and its new effects. Page:254—257
3. Drug resistance of leukemic stem cells mediated by hedgehog signaling pathway. Page:250—253
4. Recent studies on PI3K/AKT/mTOR signaling pathway in hematopoietic stem cells. Page:245—249
5. Diagnostic value of renal function parameter detection of early renal damage in multiple myeloma. Page:241—244
6. Multidrug resistance-related proteins and their relationship with acute leukemia. Page:236—240
7. Research progress on mechanism of bone marrow relapse in pediatric acute lymphoblastic leukemia. Page:231—235
8. Research progress of mesenchymal stem cell-derived microvesicle. Page:227—230
9. Latest advances of studies on microRNA regulation in dendritic cells. Page:222—226
10. Sumoylation and its role in hematological disease. Page:218—221
11. Effects of perioperative blood transfusion on the severity of postoperative infection. Page:214—217
12. Preparation and activity analysis of mouse anti human platelet CD36 monoclonal antibody. Page:209—213
13. Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia. Page:203—208
14. Construction of lentiviral vector for mouse CXC chemokine receptor 4 gene and its expression in eukaryotic cells. Page:198—202
15. Verification of multipotential mesenchymal stem cell presence in peripheral blood of rabbits. Page:193—197
16. Transfection of ECSOD to Rhesus bone marrow mesenchymal stem cells in vitro. Page:188—192
17. Biological characteristics of wharton's jelly derived mesenchymal stem cells after cryopreservation. Page:181—187
18. Effect of different cryopreservation time on quality of umbilical cord blood cells. Page:177—180
19. Impact of hepatitis B virus infection on liver function after hematopoietic stem cell transplantation. Page:173—176
20. Analysis of influence factors on G-CSF-mobilized hematopoietic stem cells of 191 healthy donors in a mono center. Page:169—172
21. Surveillance of CMV infection in allo-HSCT recipients and guidance on preemptive therapy by RQ-PCR. Page:161—168
22. Influence of donor activating or inhibitory KIR on prognosis of unmanipulated allogeneic hematopoietic stem cell transplantation. Page:155—160
23. Radiation protection effect of rhIL-12 on monkey hematopoietic system. Page:150—154
24. Treatment of children with multiple system Langerhans cell histiocytosis by Japan Langerhans Cell Histiocytosis Study Group Protocol. Page:146—149
25. Analysis of one case of adolescent blastic plasmacytoid dendritic cell neoplasm. Page:140—145
26. Polymorphisms of FcγRIIA, FcγRIIIA and FcγRIIB in patients with immune thrombocytopenia and their clinical significance. Page:135—139
27. Diagnosis model of idiopathic thrombocytopenic purpura based on platelet differential proteome. Page:130—134
28. Construction of ADAMTS13-pEGFP-N1 vector and its expression in HeLa cells. Page:126—129
29. Clinical observation of decitabine-treating patients with myelodysplastic syndrome and acute myeloid leukemia. Page:121—125
30. Detection of chromosome abnormalities in myelodysplastic syndromes with interval fluorescence in situ hybridization. Page:116—120
31. mRNA expression of telomere protection protein TIN2 and POT1 in bone marrow of patients with myelodysplastic syndrome. Page:110—115
32. Effect of gambogic acid on proliferation of SKM-1 cells and its mechanism. Page:105—109
33. Mechanisms of oxaliplatin-induced apoptosis of human multiple myeloma cell RPMI8226. Page:99—104
34. Expression of MCL-1 and microRNA-29a in extranodal NK/T-cell lymphoma tissue. Page:95—98
35. Clinical characteristics of splenic marginal zone lymphoma with abnormal complete blood count. Page:87—94
36. Effect of SUV39H1 siRNA silence on apoptosis and proliferation of acute myelogenous leukemia KG-1 cell line. Page:82—86
37. Effect of homoharringtonine on expression of NF-κB and BCL-2 proteins in K562 cells. Page:78—81
38. Effect of valproic acid against angiogenesis of Kasumi-1 xenograft tumor in nude mice. Page:73—77
39. Preliminary analysis of aberrant expression of plasma miR-223 in pediatric acute lymphoblastic leukemia with a direct RT-PCR assay. Page:68—72
40. Curative effect of decitabine combined with cytokine-induced killer cells in two elderly patients with acute myeloid leukemia. Page:62—67
41. Early detection of MRD in peripheral blood after induction chemotherapy of newly diagnosed patients with AML and its correlation with curative effects. Page:57—61
42. Synthesis of emodin derivatives and their inhibiting effects on proliferation of leukemia cell lines. Page:53—56
43. Effects of daunorubicin on KG1a cell proliferation and Eps8 expression. Page:49—52
44. Inhibition of NHE1 down-regulates IL-8 expression and enhances p38 phosphorylation. Page:45—48
45. Clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia. Page:39—44
46. Expressing trend of NME3 protein in acute myeloid leukemia HL-60 cells and patients' bone marrow. Page:34—38
47. Mutation detection of mitochondrial DNA D-loop region in bone marrow cells of acute leukemia. Page:29—33
48. Expression of Btk and NFκB in acute myeloid leukemia cells and its significance. Page:25—28
49. Expression of RAGE-1 gene in acute myeloid leukemia. Page:20—24
50. Expression of ILK and PKB/Akt in acute leukemia and its significance. Page:16—19
51. Expression of RHBDD1 gene in patients with chronic myeloid leukemia and its clinical significance. Page:12—15
52. Expression of FANCG gene in acute myeloid leukemia. Page:7—11
53. Expression of eIF4E in patients with leukemia and its clinical significance. Page:1—6